BioMarin Pharmaceuticals BMRN Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The official record: BioMarin Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioMarin Pharmaceuticals's interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioMarin Pharmaceuticals's interest income?
- BioMarin Pharmaceuticals (BMRN) reported interest income of $22.56M in Q1 2026.
- How has BioMarin Pharmaceuticals's interest income changed year-over-year?
- BioMarin Pharmaceuticals's interest income increased by 18.7% year-over-year, from $19.01M to $22.56M.
- What is the long-term trend for BioMarin Pharmaceuticals's interest income?
- Over 4 years (2021 to 2025), BioMarin Pharmaceuticals's interest income has grown at a 63.5% compound annual growth rate (CAGR), from $10.48M to $74.9M.
- What does interest income mean?
- Money earned from interest on cash holdings and investments.
- How do you interpret interest income?
- Higher interest income indicates a strong cash position and effective treasury management.
- How does interest income compare across companies?
- Varies based on the company's cash balance and prevailing market interest rates.